Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study

Giuseppe Camporese, E. Bernardi, Franco Noventa, Mario Bosco, Giuseppe Monteleone, Luca Santoro, Cristiano Bortoluzzi, Stefano Freguja, Michela Nardin, Matteo Marullo, Giacomo Zanon, Claudio Mazzola, Guido Damiani, Pietro Maniscalco, Davide Imberti, Corrado Lodigiani, Cecilia Becattini, Chiara Tonello, Giancarlo Agnelli, Chiara TonelloM. Bosco, G. Monteleone, Lucio Santoro, A. Santoliquido, A. Di Giorgio, E. Nicolardi, G. Biondi, C. Fieri, D. Dall’Acqua, A. De Matthaeis, L. Giannotta, M. Masciangelo, Giuseppe Taccardo, Rocco de Vitis, A. Militerno, S. Serpieri, V. Cilli, C. Bortoluzzi, S. Freguja, M. Nardin, Roberto Parisi, M. Marullo, A. Azzaretti, G. Zanon, C. Mazzola, G. Damiani, A. Gori, P. Cassola, Dorjan Zabzuni, C. Lodigiani, Piero Volpi, Corrado Bait, S. Vitali, M. C. Vedovati, P. Di Micco, P. Dimaro, A. Ghirarduzzi, R. Veropalumbo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences